These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26644235)

  • 41. Dural stimulation in rats causes brain-derived neurotrophic factor-dependent priming to subthreshold stimuli including a migraine trigger.
    Burgos-Vega CC; Quigley LD; Avona A; Price T; Dussor G
    Pain; 2016 Dec; 157(12):2722-2730. PubMed ID: 27841839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-migraine effect of Areca Catechu L. nut extract in bradykinin-induced plasma protein extravasation and vocalization in rats.
    Bhandare AM; Vyawahare NS; Kshirsagar AD
    J Ethnopharmacol; 2015 Aug; 171():121-4. PubMed ID: 26068422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache.
    Markowitz S; Saito K; Moskowitz MA
    Cephalalgia; 1988 Jun; 8(2):83-91. PubMed ID: 3401921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism.
    Takeda H; Sadakane C; Hattori T; Katsurada T; Ohkawara T; Nagai K; Asaka M
    Gastroenterology; 2008 Jun; 134(7):2004-13. PubMed ID: 18439428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The role of serotonin in the pathophysiology of migraine].
    Szczudlik A
    Neurol Neurochir Pol; 1992; Suppl 2():14-27. PubMed ID: 1337765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38.
    Baun M; Pedersen MH; Olesen J; Jansen-Olesen I
    Cephalalgia; 2012 Mar; 32(4):337-45. PubMed ID: 22421901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
    Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
    Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The mode of action of sumatriptan is vascular? A debate.
    Humphrey PP; Goadsby PJ
    Cephalalgia; 1994 Dec; 14(6):401-10; discussion 393. PubMed ID: 7697699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topiramate inhibits trigeminovascular activation: an intravital microscopy study.
    Akerman S; Goadsby PJ
    Br J Pharmacol; 2005 Sep; 146(1):7-14. PubMed ID: 15980877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for a control of plasma serotonin levels by 5-hydroxytryptamine(2B) receptors in mice.
    Callebert J; Esteve JM; Hervé P; Peoc'h K; Tournois C; Drouet L; Launay JM; Maroteaux L
    J Pharmacol Exp Ther; 2006 May; 317(2):724-31. PubMed ID: 16461587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat.
    Gozalov A; Jansen-Olesen I; Klaerke D; Olesen J
    Headache; 2008 Sep; 48(8):1202-13. PubMed ID: 18647185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine.
    Phebus LA; Johnson KW; Zgombick JM; Gilbert PJ; Van Belle K; Mancuso V; Nelson DL; Calligaro DO; Kiefer AD; Branchek TA; Flaugh ME
    Life Sci; 1997; 61(21):2117-26. PubMed ID: 9395253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and pharmacological evaluation of optically pure, novel carbonyl guanidine derivatives as dual 5-HT2B and 5-HT7 receptor antagonists.
    Moritomo A; Yamada H; Matsuzawa-Nomura T; Watanabe T; Itahana H; Oku M; Akuzawa S; Okada M
    Bioorg Med Chem; 2014 Nov; 22(21):6026-38. PubMed ID: 25281269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypersensitivity to meta-chlorophenylpiperazine (mCPP) in migraine and drug withdrawal.
    Kalkman HO
    Int J Clin Pharmacol Res; 1997; 17(2-3):75-7. PubMed ID: 9403358
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Episodic dural stimulation in awake rats: a model for recurrent headache.
    Oshinsky ML; Gomonchareonsiri S
    Headache; 2007; 47(7):1026-36. PubMed ID: 17635594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological migraine provocation: a human model of migraine.
    Ashina M; Hansen JM
    Handb Clin Neurol; 2010; 97():773-9. PubMed ID: 20816469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives.
    Fozard JR; Kalkman HO
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):225-9. PubMed ID: 7824037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypothesis: serotonin-1C receptor activation in migraine: an alternative point of view with therapeutic implication.
    Spierings EL
    Headache; 1991 Sep; 31(8):546-9. PubMed ID: 1960061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a Peripherally Restricted 5-HT
    Valentine MS; Bender AM; Shay S; Paffenroth KC; Gladson S; Dickerson JW; Watson KJ; Kapolka NJ; Boutaud O; Rook JM; Blackwell TS; Roth BL; Harrison FE; Austin ED; West JD; Lindsley CW; Merryman WD
    JACC Basic Transl Sci; 2023 Oct; 8(10):1379-1388. PubMed ID: 38094686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NK-mediated links for migraine.
    Martelletti P
    Cephalalgia; 1998 Jun; 18(5):242. PubMed ID: 9673801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.